Company intelligence / Profile preview

CurvaFix

Bellevue, Washington, United Statescurvafix.com ↗

Ownership: Private
Development stage: Commercial

Overview

The CurvaFix IM Implant has received FDA 510(k) clearance for fixation of pelvic fractures. Clinical use and case reports indicate strong fracture fixation with less invasive surgery, faster recovery times, reduced pain scores post-surgery, and earlier patient mobility compared to conventional techniques. Hundreds of patients have been treated since commercial launch in late 2021.

Therapeutic areas: OtherRheumatology
Modalities: DeviceImplantable medical device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on CurvaFix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CurvaFix.

Explore the full profile